Crohn ileitis

disease
On this page

Also known as Crohn's ileitis

Summary

Crohn ileitis (MONDO:0000709) is a disease and 1 clinical trial. A subtype of small bowel Crohn disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameCrohn ileitis
Mondo IDMONDO:0000709
MeSHD007079
DOIDDOID:0060189
ICD-111699481566
NCITC35329
SNOMED CT52457000
UMLSC0267380
MedGen82754
MedDRA10021312
Is cancer (heuristic)no

Also known as: Crohn’s ileitis

Disease family

This is a subtype of small bowel Crohn disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary diseaseinflammatory bowel diseaseCrohn diseasesmall bowel Crohn diseaseCrohn ileitis

Related subtypes (2): gastroduodenal Crohn disease, Crohn jejunitis

Subtypes (2): Crohn jejunoileitis, ileocolitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified1

Top trials by phase / activity

NCTPhaseStatusTitle
NCT04100005Not specifiedWITHDRAWNA Pilot Study to Explore the Role of Gut Flora in Crohn’s Disease

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.